LncPICSAR was upregulated in both primary and metastatic cSCC cell lines, promoting cutaneous carcinogenesis via the ERK1/2 signaling pathway (activation) and α2β1 and α5β1 integrin (downregulation), demonstrated by qPCR and flow cytometry analyses [54,55]. Here, MAPK3 is linked to skin squamous cell carcinoma.